Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Clin Cancer Res. 2017 Sep 22;23(23):7199–7208. doi: 10.1158/1078-0432.CCR-17-1178

Table 1.

Baseline characteristics

Median age, y (range) 58 (31–68)
ECOG performance status 0, % 100
Prior nephrectomy, % 100
MSKCC risk factors, n (%)
 0 (favorable) 25 (53)
 1–2 (intermediate) 22 (47)
 ≥ 3 (poor) 0 (0)
Metastatic sites, n
 Lungs 36
 Lymph nodes 26
 Bones 7
 Liver 6